Thrombocytopenia and Mortality in Infective Endocarditis

Journal of the American College of Cardiology

Volumn 51, Issue 18, 2008, Pages 1824-1825

  Sy, Raymond W ^a   Chawantanpipat, Chirapan ^a   Richmond, David R ^a   Kritharides, Leonard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; C REACTIVE PROTEIN;

BACTERIAL ENDOCARDITIS; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LETTER; LEUKOCYTE COUNT; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

BIOLOGICAL MARKERS; ENDOCARDITIS; HUMANS; PROGNOSIS; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 42949136879     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.01.034     Document Type: Letter

References (4)

1. Sullam P., Frank U., Yeaman M., Tauber M., Bayer A., and Chambers H. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis 168 (1993) 910-914
2. Hasbun R., Vikram H.R., Barakat L.A., Buenconsejo J., and Quagliarello V.J. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 289 (2003) 1933-1940
3. Chu V.H., Cabell C.H., Benjamin Jr. D.K., et al. Early predictors of in-hospital death in infective endocarditis. Circulation 109 (2004) 1745-1749
4. Chan K., Dumesnil J., Cujec B., et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 42 (2003) 775-780